NDRA logo

ENDRA Life Sciences Inc. (NDRA)

Profile

Full Name

ENDRA Life Sciences Inc.

Ticker

NASDAQ: NDRA

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

June 30, 2017

Indexes

Not included

Website

https://endrainc.com

Employees

21

Key Details

Price

$6.65(-0.60%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$56.94(97.94% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.65
    NDRA price is $6.65

    30-Day Relative Volume

    0.09
    NDRA 30-day relative volume is 0.09

    Price Performance

    Price Most Recent Change

    -0.6%
    NDRA price was down -0.6% on Nov 19, 2025

    Price YTD Change

    +6.23%
    NDRA price is up +6.23% since January 1st

    Price 1-Year Change

    +41.19%
    NDRA price is up +41.19% year-on-year

    Price 3-Year Change

    -99.89%
    NDRA price is down -99.89% over the past 3 years

    Price Range

    Price All-Time High

    $205800.00
    NDRA price is currently -100.00% below its historical high of $205800.00

    Price 3-Year Low

    $2.90
    NDRA price is currently +129.31% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $5.01M
    NDRA market cap is $5.01 million

    Market Cap 3-Year Change

    -54.33%
    NDRA market cap is down -54.33% over the past 3 years

    Market Cap All-Time High

    $115.08M
    NDRA market cap is currently -95.65% below its historical high of $115.08 million

    Market Cap Sector Percentile

    11.2%
    NDRA market cap is higher than 11.2% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +45.24%
    NDRA shares outstanding is up +45.24% year-on-year

    Shares Outstanding 3-Year Change

    +41722.22%
    NDRA shares outstanding is up +41722.22% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.85
    NDRA beta is 1.85

    200-day SMA

    $4.76
    NDRA price is currently +39.68% above its 200-day simple moving average

    50-day SMA

    $5.67
    NDRA price is currently +17.35% above its 50-day simple moving average

    14-Day RSI

    54.83
    NDRA 14-day relative strength index is 54.83

    Volume

    0.09
    NDRA 30-day relative volume is 0.09

    ATR

    $0.67
    NDRA average true range is $0.67

    10-day Historical Volatility

    139.24%
    NDRA 10-day historical volatility is 139.24%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    NDRA annual revenue is $0.00

    Revenue Analysts Estimate

    -
    NDRA annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    NDRA annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.68%
    NDRA annual revenue is higher than 28.68% of companies in Healthcare sector

    EPS

    EPS

    -$56.94
    NDRA annual earnings per share is -$56.94

    EPS Analysts Estimate

    -$7.48
    NDRA annual earnings per share is currently -661.23% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +97.94%
    NDRA annual earnings per share is up +97.94% year-on-year

    EPS Sector Percentile

    5%
    NDRA annual earnings per share is higher than 5% of companies in Healthcare sector

    Profit

    Gross Profit

    -$206.20K
    NDRA annual gross profit is -$206.20 thousand

    Gross Margin

    -
    NDRA annual gross profit margin value is unknown

    Operating Profit

    -$10.82M
    NDRA annual operating income is -$10.82 million

    Operating Margin

    -
    NDRA annual operating profit margin value is unknown

    Net Income

    -$11.51M
    NDRA annual net profit is -$11.51 million

    Net Margin

    -
    NDRA annual net profit margin value is unknown

    Expenses

    Total Expenses

    $10.82M
    NDRA annual total expenses is $10.82 million

    Operating Expenses

    $10.82M
    NDRA annual total operating expenses is $10.82 million

    Cost Of Goods Sold

    $206.20K
    NDRA annual cost of goods sold is $206.20 thousand

    Selling, General & Administrative Expenses

    $7.63M
    NDRA annual SG&A is $7.63 million

    Depreciation & Amortization

    $206.20K
    NDRA annual D&A is $206.20 thousand

    Interest Expense

    $0.00
    NDRA annual interest expense is $0.00

    Income Tax

    $0.00
    NDRA annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$10.82M
    NDRA annual earnings before interest & taxes is -$10.82 million

    EBITDA

    -$10.61M
    NDRA annual EBITDA is -$10.61 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $4.45M
    NDRA annual total assets is $4.45 million

    Non Current Assets

    $1.02M
    NDRA annual long term assets is $1.02 million

    Current Assets

    $3.43M
    NDRA annual total current assets is $3.43 million

    Cash and Cash Equivalents

    $3.23M
    NDRA annual cash & cash equivalents is $3.23 million

    Accounts Receivable

    -
    NDRA annual accounts receivable value is unknown

    Inventory

    $0.00
    NDRA annual inventory is $0.00

    Liabilities

    Total Liabilities

    $1.89M
    NDRA annual total liabilities is $1.89 million

    Long Term Liabilities

    $1.29M
    NDRA annual total long term liabilities is $1.29 million

    Current Liabilities

    $605.20K
    NDRA annual current liabilities is $605.20 thousand

    Accounts Payable

    $269.70K
    NDRA annual accounts payable is $269.70 thousand

    Debt

    Total Debt

    $584.40K
    NDRA annual total debt is $584.40 thousand

    Total Debt 1-Year Change

    +48.17%
    NDRA annual total debt is up +48.17% year-on-year

    Long Term Debt

    $487.50K
    NDRA annual long term debt is $487.50 thousand

    Short Term Debt

    $96.90K
    NDRA annual short term debt is $96.90 thousand

    Equity & Capital

    Shareholders Equity

    $2.56M
    NDRA annual stockholders equity is $2.56 million

    Book Value

    $2.56M
    NDRA annual book value is $2.56 million

    Retained Earnings

    -$103.44M
    NDRA annual retained earnings is -$103.44 million

    Working Capital

    $2.83M
    NDRA annual working capital is $2.83 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$7.40M
    NDRA annual cash from operations is -$7.40 million

    Cash From Operations 1-Year Change

    +22.5%
    NDRA annual cash from operations is up +22.5% year-on-year

    Cash From Investing

    -$12.80K
    NDRA annual cash from investing is -$12.80 thousand

    Cash From Investing 1-Year Change

    +48.18%
    NDRA annual cash from investing is up +48.18% year-on-year

    Cash From Financing

    $7.81M
    NDRA annual cash from financing is $7.81 million

    Cash From Financing 1-Year Change

    +3.87%
    NDRA annual cash from financing is up +3.87% year-on-year

    CAPEX

    CAPEX

    $16.00K
    NDRA annual capital expenditures is $16.00 thousand

    CAPEX 1-Year Change

    -52.8%
    NDRA annual capital expenditures is down -52.8% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$7.42M
    NDRA annual free cash flow is -$7.42 million

    Free Cash Flow 1-Year Change

    +22.61%
    NDRA annual free cash flow is up +22.61% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    NDRA annual gross profit margin value is unknown

    Operating Margin

    -
    NDRA annual operating profit margin value is unknown

    Net Margin

    -
    NDRA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -205.38%
    NDRA annual return on assets is -205.38%

    ROE

    -280.02%
    NDRA annual return on equity is -280.02%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    NDRA price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    NDRA price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    29.21
    NDRA price to book ratio is 29.21

    PB Ratio Sector Percentile

    95.71%
    NDRA price to book ratio is higher than 95.71% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    NDRA price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    NDRA price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $4.74M
    NDRA enterprise value is $4.74 million

    Enterprise Value Sector Percentile

    17.73%
    NDRA enterprise value is higher than 17.73% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.57
    NDRA EV/EBITDA is -0.57

    EV/EBITDA Sector Percentile

    52.21%
    NDRA EV/EBITDA is higher than 52.21% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    5.67
    NDRA annual current ratio is 5.67

    Quick Ratio

    5.67
    NDRA annual quick ratio is 5.67

    Leverage

    Debt To Equity

    0.23
    NDRA annual debt to equity ratio is 0.23

    Interest Coverage Ratio

    -
    NDRA annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    NDRA piotroski f-score value is unknown

    Altman Z-Score

    -38.19
    NDRA altman z-score is -38.19

    Analyst ratings

    Recent major analysts updates

    Sep 22, 25 Ascendiant Capital
    Buy
    May 30, 25 Ascendiant Capital
    Buy
    Apr 21, 25 Ascendiant Capital
    Buy
    Jun 7, 24 Ascendiant Capital
    Buy
    Mar 31, 23 HC Wainwright & Co.
    Buy
    Apr 7, 22 HC Wainwright & Co.
    Buy
    Jul 15, 19 H.C. Wainwright
    Buy
    May 20, 19 Lake Street
    Buy

    Institutional Ownership

    Screeners with NDRA included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for ENDRA Life Sciences Inc.?
    • Does ENDRA Life Sciences Inc. pay dividends?
    • What sector is ENDRA Life Sciences Inc. in?
    • What industry is ENDRA Life Sciences Inc. in?
    • What country is ENDRA Life Sciences Inc. based in?
    • When did ENDRA Life Sciences Inc. go public?
    • Is ENDRA Life Sciences Inc. in the S&P 500?
    • Is ENDRA Life Sciences Inc. in the NASDAQ 100?
    • Is ENDRA Life Sciences Inc. in the Dow Jones?
    • When was ENDRA Life Sciences Inc.'s last earnings report?
    • When does ENDRA Life Sciences Inc. report earnings?

    What is the ticker symbol for ENDRA Life Sciences Inc.?

    The ticker symbol for ENDRA Life Sciences Inc. is NASDAQ:NDRA

    Does ENDRA Life Sciences Inc. pay dividends?

    No, ENDRA Life Sciences Inc. does not pay dividends

    What sector is ENDRA Life Sciences Inc. in?

    ENDRA Life Sciences Inc. is in the Healthcare sector

    What industry is ENDRA Life Sciences Inc. in?

    ENDRA Life Sciences Inc. is in the Diagnostics & Research industry

    What country is ENDRA Life Sciences Inc. based in?

    ENDRA Life Sciences Inc. is headquartered in United States

    When did ENDRA Life Sciences Inc. go public?

    ENDRA Life Sciences Inc.'s initial public offering (IPO) was on June 30, 2017

    Is ENDRA Life Sciences Inc. in the S&P 500?

    No, ENDRA Life Sciences Inc. is not included in the S&P 500 index

    Is ENDRA Life Sciences Inc. in the NASDAQ 100?

    No, ENDRA Life Sciences Inc. is not included in the NASDAQ 100 index

    Is ENDRA Life Sciences Inc. in the Dow Jones?

    No, ENDRA Life Sciences Inc. is not included in the Dow Jones index

    When was ENDRA Life Sciences Inc.'s last earnings report?

    ENDRA Life Sciences Inc.'s most recent earnings report was on August 22, 2025

    When does ENDRA Life Sciences Inc. report earnings?

    The date for ENDRA Life Sciences Inc.'s next earnings report has not been announced yet
    On this page